Table 2.
n | LI of β-catenin accumulated type | EI of β-catenin mRNA | |
Male | 31 | 58.4 ± 14.2 | 0.8 ± 0.2 |
Female | 3 | 54.1 ± 15.3 | 0.9 ± 0.1 |
AFP ≤ 20 ng/mL | 9 | 49.3 ± 17.2 | 0.8 ± 0.1 |
AFP > 20 ng/mL | 25 | 54.3 ± 13.7 | 0.8 ± 0.1 |
Tumor size | |||
≤ 5 cm | 15 | 58.7 ± 20.4 | 0.8 ± 0.2 |
5 cm~10 cm | 7 | 54.4 ± 21.3 | 0.8 ± 0.2 |
> 10 cm | 12 | 55.9 ± 17.9 | 0.8 ± 0.1 |
Capsule | |||
Complete | 15 | 72.2 ± 23.4 | 0.7 ± 0.1 |
Incomplete | 19 | 44.4 ± 21.1b | 0.9 ± 0.1a |
Intrahepatic Metastasis Yes | 14 | 77.2 ± 25.5 | 0.9 ± 0.2 |
Intrahepatic Metastasis No | 20 | 41.3 ± 19.6b | 0.7 ± 0.1a |
Portal vein thrombus Yes | 19 | 79.8 ± 14.9 | 0.9 ± 0.2 |
Portal vein thrombus No | 15 | 52.8 ± 25.9a | 0.6 ± 0.2a |
Edmondson’s Grade II | 19 | 39.7 ± 20.0 | 0.7 ± 0.4 |
Edmondson’s Grade III | 15 | 75.9 ± 18.7b | 0.8 ± 0.2 |
Cirrhotic nodule ≤ 0.5 cm | 23 | 54.3 ± 12.5 | 0.8 ± 0.2 |
Cirrhotic nodule >0.5 cm | 11 | 62.2 ± 16.6 | 0.8 ± 0.1 |
P < 0.05,
P < 0.01.